摘要
目的 了解纳络酮在急性心肌梗塞 (AMI)并心源性休克中的作用及对其预后的影响。方法 收集我院近 4年来AMI并发心源性休克的患者 35例 ,随机分普通组 17例和纳络酮组 18例进行救治。结果 常规组有效率为 2 9.4% ,纳络酮组有效率为 6 1.1% ,经x2 检验 ,P <0 .0 5 ,有显著性差异 .结论 AMI并心源性休克在无条件实施急诊血运重建术的医院 ,在常规治疗的基础上加用纳络酮治疗 ,可显著提高有效率 。
Objective To explore the effect of Naloxon in treating AMI and Cardigenic shock patients and its influence on future anticipation. Methods 35 cases during the last 4 years were collected and randomly divided into normal group (17 cases) and Naloxon group (18 cases) to receive respective treatment. Results The effective rate of Naloxon group was 61.5% and that of Normal group 29.4% ( P <0.05) Obvious difference existed.Conclusion Naloxon plus normal treatinent Can improve the effoctive rate and cut down the death rate remarkably of AMI and cardigenic shock patients in hospitals without condition to carry out anurgent operation to rebuild the route blood circulation.
出处
《湖北民族学院学报（医学版）》
2001年第3期12-13,共2页
Journal of Hubei Minzu University(Medical Edition)
关键词
急性心肌梗塞
并发症
休克
纳络酮
AMI/complication
cardigenic schock
naloxdn/therapy application
